15 May 2019

Gene editing technology stirs up ethical dilemma

The world of medicinal biotechnology is voyaging into the unknown.


Australia has taken the bold step of approving a technology called “CRISPR” in the hope of developing breakthrough cures for a host of ailments and diseases. 

However, the move is somewhat controversial because of its potential side effects.

Otherwise known as “clustered regularly interspaced short palindromic repeats”, CRISPR is a novel gene-editing technology that exploits quirks in bacteria immunity to edit genes in other organisms.

The new technology has spurred dozens of labs around the world into developing the next generation of medical breakthroughs.




Written by George Tchetvertakov
Published by Small Caps